Guardant Health Inc (NAS:GH)
$ 23.52 -0.08 (-0.34%) Market Cap: 2.89 Bil Enterprise Value: 3.22 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 05:00PM GMT
Release Date Price: $77.45 (+6.83%)
Xiaoxiao Ma
BofA Merrill Lynch, Research Division - Associate

I'm Ivy Ma. I work on the Life Sciences Tools and Diagnostics team here at BofA. Welcome to day 2 of our Vegas Healthcare Conference. Well, before we go ahead and introduce our next session here, wanted to thank you for everyone for being here. I'm here on behalf of my Senior Analyst, Derik De Bruin, who unfortunately couldn't travel because he's recovering from some surgery, but he's here in spirit with us and also listening to the webcast.

That said, Derik would really appreciate if I make the -- I ask. I know you probably already heard this many times, but it's still my job to ask and definitely appreciate your support or feedback for Life Sciences Tools and Diagnostic team as well as the entire BofA research team.

Now moving on to more important things. So next up, we have Guardant's CEO, Helmy; as well as CFO, Derek. Welcome to the stage. Thank you very much for being here and they have a presentation.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot